[논문]Analysis of HR-HPV Prevalence among Unvaccinated Busan Women

Dong Hyeok Kim; Kyung Eun Lee

doi:10.15616/bsl.2022.28.4.229

Analysis of HR-HPV Prevalence among Unvaccinated Busan Women 원문보기

Biomedical science letters = 대한의생명과학회지, v.28 no.4, 2022년, pp.229 - 236

Dong Hyeok Kim (Department of Clinical Laboratory Science, Catholic University of Pusan) , Kyung Eun Lee (Department of Clinical Laboratory Science, Catholic University of Pusan)

Abstract ▼ AI-Helper

To prevent cervical cancer, human papillomavirus (HPV) bivalent and quadrivalent vaccinations are common, but there is a need for a vaccination system based on the high-risk human papillomavirus (HR-HPV) genotype that differs by region. This study aimed to investigate the prevalence of HPV and the distribution of HR-HPV genotypes in 2,014 women who were not vaccinated against HPV. In this study, HPV DNA testing was performed on 2,014 women not vaccinated against HPV and who visited the Busan Obstetrics and Gynecology Department from September 2020 to July 2021. In addition, liquid-based cytology (LBC) test was performed on 493 cases of HR- HPV genotype infection confirmed by HPV DNA test. The prevalence of HPV among women in Busan was positive in 609 (30.2%) out of 2,014 cases. Among the 609 HPV-positive cases, HR-HPV infection accounted for 493 cases (81.0%), which is a high proportion. Of the total 493 HR-HPV infection cases, liquid-based cytology (LBC) was within normal limits (WNL) in 266 cases (54.0%), atypical squamous cells of undetermined significance (ASCUS) in 97 cases (19.7%), low-grade squamous intraepithelial lesion (LGSIL) in 88 cases (17.8%), and high-grade squamous intraepithelial lesion (HGSIL) in 42 cases (8.5%). Single HR-HPV 52 and 16 accounted for the highest and second highest infection rates, respectively. The high infection rate among women aged 18~39 underscores the need for continuous monitoring. In addition, when there were abnormal findings in the cervical epithelium, HPV 52 was the most common, while in the case of HGSIL, HPV 16 was the most common. The HR-HPV genotypes related to cervical cancer should be continuously collected and monitored for use in health policies, including local and national vaccinations.

주제어

참고문헌 (28)

Aro K, Nieminen P, Louvanto K, Jakobsson M, Virtanen S,？Lehtinen M, Dillner J, Kalliala I. Age-specific hpv type？distribution in high-grade cervical disease in screened and？unvaccinated women. Gynecol Oncol. 2019. 154: 354-359.

상세보기
Burd EM. Human papillomavirus and cervical cancer. Clin？Microbiol Rev. 2003. 16: 1-17.

상세보기
Castle PE. Beyond human papillomavirus: The cervix, exogenous？secondary factors, and the development of cervical precancer？and cancer. J Low Genit Tract Dis. 2004. 8: 224-230.

상세보기
Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ,？Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E,？Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR,？Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi？S. Worldwide distribution of human papillomavirus types in？cytologically normal women in the international agency for？research on cancer hpv prevalence surveys: A pooled analysis.？Lancet. 2005. 366: 991-998.

상세보기
Cubie HA. Diseases associated with human papillomavirus infection. Virology. 2013. 445: 21-34.

상세보기
de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L,？Munoz N, Bosch FX. Worldwide prevalence and genotype？distribution of cervical human papillomavirus DNA in women？with normal cytology: A meta-analysis. Lancet Infect Dis. 2007. 7: 453-459.

상세보기
Drolet M, Benard E, Perez N, Brisson M, Ali H, Boily MC, Baldo？V, Brassard P, Brotherton JML, Callander D, Checchi M,？Chow EPF, Cocchio S, Dalianis T, Deeks SL, Dehlendorff C,？Donovan B, Fairley CK, Flagg EW, Gargano JW, et al.？Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes:？Updated systematic review and meta-analysis. The Lancet. 2019. 394: 497-509.

상세보기
Hong S, Won YJ, Lee JJ, Jung KW, Kong HJ, Im JS, Seo HG.？Cancer statistics in korea: Incidence, mortality, survival, and？prevalence in 2018. Cancer Res Treat. 2021. 53: 301-315.

상세보기
Kim MA, Han GH, Kim JH, Seo K. Current status of human？papillomavirus infection and introduction of vaccination to？the national immunization program in korea: An overview. J？Korean Med Sci. 2018. 33: e331.
Kind AB, Pavelyev A, Kothari S, El Mouaddin N, Schmidt A,？Morais E, Guggisberg P, Lienert F. Assessing the epidemiological impact on cervical cancer of switching from 4-valent？to 9-valent hpv vaccine within a gender-neutral vaccination？programme in switzerland. BMC Public Health. 2020. 20: 671.

상세보기
Krashias G, Koptides D, Christodoulou C. Hpv prevalence and？type distribution in cypriot women with cervical cytological？abnormalities. BMC Infect Dis. 2017. 17: 346.
Long W, Yang Z, Li X, Chen M, Liu J, Zhang Y, Sun X. Hpv-16,？hpv-58, and hpv-33 are the most carcinogenic hpv genotypes？in southwestern china and their viral loads are associated？with severity of premalignant lesions in the cervix. Virol J. 2018. 15: 94.

상세보기
Ma DM, Sun MX, Li XY, Li S, Nie XJ, Jin DH, Chen LM.？Distribution of high-risk human papillomavirus genotypes in？male attendees at a clinic for sexually transmitted infections？in northern china. Eur Rev Med Pharmacol Sci. 2019. 23:？9714-9720.
Malagon T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J,？Brisson M. Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-analysis.？Lancet Infect Dis. 2012. 12: 781-789.

상세보기
Martins TR, Mendes de Oliveira C, Rosa LR, de Campos Centrone？C, Rodrigues CL, Villa LL, Levi JE. Hpv genotype distribution in brazilian women with and without cervical lesions:？Correlation to cytological data. Virol J. 2016. 13: 138.

상세보기
Min KJ, Kwon SH, Kim S, Kim HJ, Seong SJ, Song YJ, Shin JW,？Lee KH, Lim MC, Chung HH, Ju W, Hong JH, Lee JW, Kim？JW, Bae DS, Lee JK. Preventive vaccination against cervical？cancer: Korean society of gynecologic oncology guideline. J？Gynecol Oncol. 2016. 27: e30.
Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X,？Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification？of human papillomavirus types associated with cervical cancer.？N Engl J Med. 2003. 348: 518-527.

상세보기
Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000. 151: 1158-1171.

상세보기
Park E, Kim JY, Choi S, Kim DS, Oh YL. Carcinogenic risk of？human papillomavirus (hpv) genotypes and potential effects？of hpv vaccines in korea. Sci Rep. 2019. 9: 12556.

상세보기
Paz-Zulueta M, Alvarez-Paredes L, Rodriguez Diaz JC, Paras-Bravo P, Andrada Becerra ME, Rodriguez Ingelmo JM, Ruiz？Garcia MM, Portilla J, Santibanez M. Prevalence of high-risk？hpv genotypes, categorised by their quadrivalent and ninevalent hpv vaccination coverage, and the genotype association？with high-grade lesions. BMC Cancer. 2018. 18: 112.

상세보기
Printz C. Fda approves gardasil 9 for more types of hpv. Cancer. 2015. 121: 1156-1157.

상세보기
Sabol I, Milutin Gasperov N, Matovina M, Bozinovic K, Grubisic？G, Fistonic I, Belci D, Alemany L, Dzebro S, Dominis M,？Sekerija M, Tous S, de Sanjose S, Grce M. Cervical hpv？type-specific pre-vaccination prevalence and age distribution？in croatia. PLoS One. 2017. 12: e0180480.

상세보기
Sasagawa T, Basha W, Yamazaki H, Inoue M. High-risk and？multiple human papillomavirus infections associated with？cervical abnormalities in japanese women. Cancer Epidemiol？Biomarkers Prev. 2001. 10: 45-52.
Topazian HM, Kundu D, Peebles K, Ramos S, Morgan K, Kim？CJ, Richter KL, Brewer NT, Peris M, Smith JS. Hpv vaccination recommendation practices among adolescent health care？providers in 5 countries. J Pediatr Adolesc Gynecol. 2018. 31:？575-582.e572.

상세보기
Tran KN, Park Y, Kim BW, Oh JK, Ki M. Incidence and mortality of cervical cancer in vietnam and korea (1999-2017).？Epidemiol Health. 2020. 42: e2020075.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA,？Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human？papillomavirus is a necessary cause of invasive cervical cancer？worldwide. J Pathol. 1999. 189: 12-19.

상세보기
WHO. Human papillomavirus vaccines: Who position paper,？october 2014. Wkly Epidemiol Rec. 2014. 89: 465-491.

상세보기
Won S, Kim MK, Seong SJ. Clinical management of abnormal？pap tests: Differences between us and korean guidelines. J？Pathol Transl Med. 2020. 54: 213-219.

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Analysis of HR-HPV Prevalence among Unvaccinated Busan Women 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (28)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트